CD8A and COVID-19: The level of cytotoxic CD8+ T-lymphocytes in the peripheral blood of patients with COVID-19 seemed unchanged, but there was a decrease in ‘naïve’ CD3+CD8+ cells in circulation accompanied by an increased proportion of cells at the later stages of differentiation [38].